Remote Medical Director - Oncology Clinical Development

Sumitomo Pharma; Trenton (NJ); Remote; USD 226,000 - 282,000; Full time

Job summary

Sumitomo Pharma America, Inc. seeks an Associate Medical Director, Clinical Development – Oncology to lead design and execution of early-to-late-stage trials and regulatory submissions.

Focus on hematological malignancies; global collaboration with investigators and partners; US-Remote, full-time role supporting a growing oncology portfolio. MD/DO required with residency completed; subspecialty fellowship desirable; 0–3 years pharma development experience preferred.

Qualifications

• MD/DO or international equivalent required.
• Residency completion strongly preferred.
• Subspecialty fellowship desirable.
• Experience in blood cancers or solid tumors desirable.
• 0 to 3 years of pharmaceutical drug development experience required.

Responsibilities

• Design and implement clinical protocol aligned with development plan.
• Provide medical input to protocols and regulatory documents.
• Lead clinical study teams and ensure data integrity.
• Present findings at scientific and regulatory meetings.
• Collaborate with investigators, KOLs, and partners.
• Contribute to INDs/NDAs sections.
• Assess safety with Drug Safety & Pharmacovigilance.
• Maintain up-to-date knowledge through literature and meetings.

Skills

Hematological malignancies

Clinical trial design

Regulatory strategy

Leadership

Cross-functional collaboration

Medical writing

Scientific presentation

Regulatory filings

Drug safety awareness

Education

MD/DO or non-US equivalent

Residency completion

Subspecialty fellowship desirable

Job description

Sumitomo Pharma America, Inc. seeks an Associate Medical Director, Clinical Development – Oncology to lead design and execution of early-to-late-stage trials and regulatory submissions.

Focus on hematological malignancies; global collaboration with investigators and partners; US-Remote, full-time role supporting a growing oncology portfolio. MD/DO required with residency completed; subspecialty fellowship desirable; 0–3 years pharma development experience preferred.